{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:18:52Z","timestamp":1783693132588,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007834","name":"Natural Science Foundation of Ningbo Municipality","doi-asserted-by":"publisher","award":["2024J381"],"award-info":[{"award-number":["2024J381"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.molimm.2026.05.010","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:27:55Z","timestamp":1780936075000},"page":"35-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Combined targeting of mesothelin and tenascin-C enhances CAR-T cell function and tumor microenvironment modulation in ovarian cancer"],"prefix":"10.1016","volume":"196","author":[{"given":"Xiaoqin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duoyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.molimm.2026.05.010_bib1","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.3390\/cancers14194706","article-title":"Strategies for efficient targeting of tumor collagen for cancer therapy","volume":"14","author":"Baldari","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.molimm.2026.05.010_bib2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2147\/ITT.S291767","article-title":"Fibroblast activation protein (FAP)-targeted CAR-T cells: launching an attack on tumor stroma","volume":"10","author":"Bughda","year":"2021","journal-title":"Immunotargets Ther."},{"key":"10.1016\/j.molimm.2026.05.010_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1172681","article-title":"Stromal depletion by TALEN-edited universal hypoimmunogenic FAP-CAR T cells enables infiltration and anti-tumor cytotoxicity of tumor antigen-targeted CAR-T immunotherapy","volume":"14","author":"Das","year":"2023","journal-title":"Front Immunol."},{"issue":"11","key":"10.1016\/j.molimm.2026.05.010_bib4","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1158\/2326-6066.CIR-25-1097","article-title":"CAR-ving a Path: Metalloprotease-Engineered CAR T Cells Tunnel through Solid Tumors","volume":"13","author":"Gasparetto","year":"2025","journal-title":"Cancer Immunol. Res"},{"issue":"16","key":"10.1016\/j.molimm.2026.05.010_bib5","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.3390\/cancers14163906","article-title":"Cancer-associated fibroblasts: tumorigenicity and targeting for cancer therapy","volume":"14","author":"Glabman","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.molimm.2026.05.010_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2023.103020","article-title":"Advances in promoting chimeric antigen receptor T cell trafficking and infiltration of solid tumors","volume":"84","author":"Hong","year":"2023","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.molimm.2026.05.010_bib7","article-title":"Use of a universal targeting CAR T cell to simultaneously kill cancer cells and cancer-associated fibroblasts","volume":"16","author":"Huang","year":"2025","journal-title":"Front Immunol."},{"key":"10.1016\/j.molimm.2026.05.010_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122101","article-title":"Mechano-modulation of T cells for cancer immunotherapy","volume":"297","author":"Hyun","year":"2023","journal-title":"Biomaterials"},{"issue":"15","key":"10.1016\/j.molimm.2026.05.010_bib9","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1158\/0008-5472.CAN-23-3007","article-title":"Human 3D ovarian cancer models reveal malignant cell-intrinsic and -extrinsic factors that influence CAR T-cell activity","volume":"84","author":"Joy","year":"2024","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.molimm.2026.05.010_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/curroncol32020079","article-title":"Tumor-associated extracellular matrix obstacles for CAR-T cell therapy: approaches to overcoming","volume":"32","author":"Klabukov","year":"2025","journal-title":"Curr. Oncol."},{"issue":"10","key":"10.1016\/j.molimm.2026.05.010_bib11","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.trecan.2025.08.009","article-title":"Overcoming solid-tumor barriers: armored CAR-T cell therapy","volume":"11","author":"Kwon","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.molimm.2026.05.010_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1367875","article-title":"Endothelial cells in tumor microenvironment: insights and perspectives","volume":"15","author":"Leone","year":"2024","journal-title":"Front Immunol."},{"issue":"12","key":"10.1016\/j.molimm.2026.05.010_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1141","article-title":"Engineering chimeric antigen receptor T cells for solid tumour therapy","volume":"12","author":"Liu","year":"2022","journal-title":"Clin. Transl. Med"},{"key":"10.1016\/j.molimm.2026.05.010_bib14","first-page":"1","article-title":"Impact of tumor microenvironment on adoptive T cell transfer activity","volume":"370","author":"Mart\u00edn-Otal","year":"2022","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.molimm.2026.05.010_bib15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/bs.apcsb.2024.02.004","article-title":"Immunotherapy guided precision medicine in solid tumors","volume":"140","author":"Mehrotra","year":"2024","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"10.1016\/j.molimm.2026.05.010_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1506204","article-title":"Relaxin-2-secreting CAR-T cells exhibit enhanced efficacy in stromal-rich xenograft tumors","volume":"16","author":"Ogawa","year":"2025","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.molimm.2026.05.010_bib17","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1038\/s41467-023-40852-3","article-title":"Low-dose carboplatin modifies the tumor microenvironment to augment CAR T cell efficacy in human prostate cancer models","volume":"14","author":"Porter","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molimm.2026.05.010_bib18","doi-asserted-by":"crossref","unstructured":"Redondo-Frutos, R.A., Justicia-Lirio, P., Barbero-Jimenez, C., , 2025. Genetic Engineering in CAR T Cells for Solid Tumors: Current State, Barriers and Future Developments. Hum Gene Ther. 2025;36(17-18):1138-1153..","DOI":"10.1177\/10430342251372041"},{"key":"10.1016\/j.molimm.2026.05.010_bib19","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3389\/fimmu.2020.01109","article-title":"CAR-T cells hit the tumor microenvironment: strategies to overcome tumor escape","volume":"11","author":"Rodriguez-Garcia","year":"2020","journal-title":"Front Immunol."},{"issue":"11","key":"10.1016\/j.molimm.2026.05.010_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-011382","article-title":"Targeting the extracellular matrix with Tenascin-C-specific CAR T cells extends survival in preclinical models of glioblastoma","volume":"13","author":"de Sostoa","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.molimm.2026.05.010_bib21","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.molimm.2026.05.010_bib22","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/1744666X.2024.2380894","article-title":"CAR-T cell technologies that interact with the tumour microenvironment in solid tumours","volume":"20","author":"Taylor","year":"2024","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"4","key":"10.1016\/j.molimm.2026.05.010_bib23","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"11","key":"10.1016\/j.molimm.2026.05.010_bib24","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1158\/2326-6066.CIR-25-0149","article-title":"Tunneling CARs: increasing CAR T-Cell Tumor Infiltration through the Overexpression of MMP-7 and Osteopontin-b","volume":"13","author":"Van Pelt","year":"2025","journal-title":"Cancer Immunol. Res."},{"issue":"3","key":"10.1016\/j.molimm.2026.05.010_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008431","article-title":"An oncolytic vaccinia virus encoding hyaluronidase reshapes the extracellular matrix to enhance cancer chemotherapy and immunotherapy","volume":"12","author":"Wang","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"6","key":"10.1016\/j.molimm.2026.05.010_bib26","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1021\/acsnano.2c10845","article-title":"Extracellular matrix viscosity reprogramming by in situ Au bioreactor-boosted microwavegenetics disables tumor escape in CAR-T immunotherapy","volume":"17","author":"Wang","year":"2023","journal-title":"ACS Nano"},{"issue":"13","key":"10.1016\/j.molimm.2026.05.010_bib27","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1016\/j.cell.2024.04.023","article-title":"Osr2 functions as a biomechanical checkpoint to aggravate CD8+ T cell exhaustion in tumor","volume":"187","author":"Zhang","year":"2024","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.molimm.2026.05.010_bib28","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1021\/acscentsci.2c00163","article-title":"Bioorthogonal equipping CAR-T cells with hyaluronidase and checkpoint blocking antibody for enhanced solid tumor immunotherapy","volume":"8","author":"Zhao","year":"2022","journal-title":"ACS Cent. Sci."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016158902600129X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016158902600129X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:01:38Z","timestamp":1783692098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016158902600129X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":28,"alternative-id":["S016158902600129X"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2026.05.010","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined targeting of mesothelin and tenascin-C enhances CAR-T cell function and tumor microenvironment modulation in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2026.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}